 sclerotherapi esophag varic thrombogen cocktail short- long-term efficaci thrombogen scleros tetradecyl sulfat thrombin cefazolin patient major patient alcohol cirrhosi child classif bleed cent patient first sclerotherapi in-hospit earli week mortal cent cent strong correl hospit mortal sever hepat diseas long-term follow-up patient mean month surviv complianc follow-up sclerotherapi abstent alcohol intak mortal patient compliant follow-up cent cent patient compliant follow-up sclerotherapi mortal alcohol cirrhot patient alcohol intak cent cent alcohol system thrombot allerg event use bovin thrombin total sclerotherapi session